Literature DB >> 14701750

Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.

Koh Fujinaga1, Dan Irwin, Yehong Huang, Ran Taube, Takeshi Kurosu, B Matija Peterlin.   

Abstract

The elongation of transcription is a highly regulated process that requires negative and positive effectors. By binding the double-stranded stem in the transactivation response (TAR) element, RD protein from the negative transcription elongation factor (NELF) inhibits basal transcription from the long terminal repeat of the human immunodeficiency virus type 1 (HIVLTR). Tat and its cellular cofactor, the positive transcription elongation factor b (P-TEFb), overcome this negative effect. Cdk9 in P-TEFb also phosphorylates RD at sites next to its RNA recognition motif. A mutant RD protein that mimics its phosphorylated form no longer binds TAR nor represses HIV transcription. In sharp contrast, a mutant RD protein that cannot be phosphorylated by P-TEFb functions as a dominant-negative effector and inhibits Tat transactivation. These results better define the transition from abortive to productive transcription and thus replication of HIV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14701750      PMCID: PMC343783          DOI: 10.1128/MCB.24.2.787-795.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

Review 1.  Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

Authors:  R Taube; K Fujinaga; J Wimmer; M Barboric; B M Peterlin
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Stimulation of RNA polymerase II elongation by hepatitis delta antigen.

Authors:  Y Yamaguchi; J Filipovska; K Yano; A Furuya; N Inukai; T Narita; T Wada; S Sugimoto; M M Konarska; H Handa
Journal:  Science       Date:  2001-05-31       Impact factor: 47.728

4.  Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.

Authors:  S H Chao; K Fujinaga; J E Marion; R Taube; E A Sausville; A M Senderowicz; B M Peterlin; D H Price
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

Review 5.  Transcriptional antitermination.

Authors:  J Greenblatt; J R Nodwell; S W Mason
Journal:  Nature       Date:  1993-07-29       Impact factor: 49.962

6.  Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.

Authors:  D K Lee; H O Duan; C Chang
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

7.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.

Authors:  S Kanazawa; T Okamoto; B M Peterlin
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

8.  DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.

Authors:  Y H Ping; T M Rana
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

9.  FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.

Authors:  T Wada; G Orphanides; J Hasegawa; D K Kim; D Shima; Y Yamaguchi; A Fukuda; K Hisatake; S Oh; D Reinberg; H Handa
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

10.  Domains in the SPT5 protein that modulate its transcriptional regulatory properties.

Authors:  D Ivanov; Y T Kwak; J Guo; R B Gaynor
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

View more
  170 in total

1.  Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex.

Authors:  Anamika Missra; David S Gilmour
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

Review 2.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

Review 3.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 4.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

5.  Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion.

Authors:  Matjaz Barboric; Tina Lenasi
Journal:  Nat Struct Mol Biol       Date:  2010-08       Impact factor: 15.369

6.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

Review 7.  Molecular mechanisms of HIV latency.

Authors:  Daniele C Cary; Koh Fujinaga; B Matija Peterlin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

8.  PAF1, a Molecular Regulator of Promoter-Proximal Pausing by RNA Polymerase II.

Authors:  Fei Xavier Chen; Ashley R Woodfin; Alessandro Gardini; Ryan A Rickels; Stacy A Marshall; Edwin R Smith; Ramin Shiekhattar; Ali Shilatifard
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

9.  An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription.

Authors:  Matthieu Giraud; Nada Jmari; Lina Du; Floriane Carallis; Thomas J F Nieland; Flor M Perez-Campo; Olivier Bensaude; David E Root; Nir Hacohen; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-16       Impact factor: 11.205

10.  Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation.

Authors:  Matjaz Barboric; Fan Zhang; Mojca Besenicar; Ana Plemenitas; B Matija Peterlin
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.